Frontline PLC FRO
47.73
(0.24)
(0.50%)
as of 25 Sep
- Market cap
- $10.5B
- P/E
- 7.1×
Follow FRO
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
5.22 | 8.59 | 12.84 | 23.26 |
+8 more quarters Free account |
P/S ratio |
2.57 | 3.14 | 2.46 | 2.85 | |
P/FCF ratio |
4.58 | 5.33 | 6.87 | 7.93 | |
P/Operating CF |
13.37 | 20.30 | 17.14 | 47.43 | |
P/B ratio |
2.46 | 2.73 | 1.93 | 2.20 | |
Price to Tangible BV |
2.55 | 2.85 | 2.03 | 2.31 | |
EV/Sales |
3.27 | 4.01 | 3.89 | 4.55 | |
EV/EBITDA |
6.05 | 9.10 | 12.81 | 18.09 | |
EV/Operating CF |
7.29 | 10.71 | 11.24 | 14.38 | |
EV/FCF |
5.83 | 6.81 | 10.85 | 12.67 | |
Quick Ratio |
0.66 | 1.00 | 0.81 | 0.44 | |
Current Ratio |
1.87 | 2.03 | 1.43 | 1.37 | |
Net Debt/EBITDA |
3.15 | 3.69 | 10.13 | 31.76 | |
Debt/Assets |
41.89% | 46.44% | 53.32% | 56.73% | |
Debt/Equity |
0.77 | 0.93 | 1.22 | 1.39 | |
Asset Turnover |
0.51 | 0.42 | 0.33 | 0.30 | |
Operating CF/Net income |
0.88 | 0.68 | 1.24 | 2.67 | |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
1.23% | 2.79% | 1.79% | 3.50% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.89% | 0.00% | |
Graham Net Nets |
(0.23) | (0.24) | (0.52) | (0.55) | |
Graham Number |
46.11 | 34.13 | 20.77 | 15.13 | |
Earnings Yield |
19.17% | 11.65% | 7.79% | 4.30% | |
Free Cash Flow Yield |
21.84% | 18.75% | 14.56% | 12.61% | |
Revenue per Share |
4.57 | 4.17 | 2.81 | 1.96 | |
Operating CF per Share |
2.60 | 1.72 | 1.27 | 0.48 | |
Capex per Share |
(0.86) | 2.26 | (0.03) | 0.15 | |
Free Cash Flow per Share |
1.74 | 3.98 | 1.24 | 0.63 | |
Cash per Share |
1.45 | 2.12 | 1.14 | 0.86 | |
Shareholders Equity per Share |
14.17 | 12.75 | 11.28 | 10.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.17 | 12.75 | 11.28 | 10.38 | |
Free Cash Flow |
387.25 | 886.74 | 276.46 | 141.55 | |
Working Capital |
424.42 | 487.64 | 212.55 | 161.61 | |
Capital Expenditures |
(192.24) | 504.25 | (6.89) | 33.91 | |
Net Current Asset Value |
(1,745.66) | (1,865.58) | (2,535.50) | (2,785.31) | |
EV/EBIT |
6.05 | 9.10 | 12.81 | 18.09 | |
Capex to Sales |
0.19 | (0.54) | 0.01 | (0.08) | |
Net Profit Margin |
64.71% | 60.16% | 36.50% | 9.19% | |
Price to Operating Income |
4.75 | 7.12 | 8.11 | 11.33 | |
| Other line items | |||||
Average Receivables |
— | — | 116.15 | — | |
Average Payables |
— | — | 93.24 | — | |
Average Inventory |
— | — | 100.43 | — | |
Average Assets |
5,961.13 | 5,901.94 | 5,987.22 | 5,996.99 | |
Average Common Equity |
2,760.45 | 2,584.81 | 2,425.53 | 2,336.59 |
Columns are period end dates